retatrutide effect on glucagon is drawing major attention in metabolic and liver research., Researchers are studying how triple receptor agonism (GIP / GLP-1 / glucagon) may influence:, • Liver fat metabolism, • Energy There's so much talk about

Crucially, this glucose-dependent mechanism means insulin is only released when blood glucose levels are elevated, thereby reducing the risk of hypoglycaemia compared with some other diabetes medications

Glucagon receptor activation increases hepatic glucose production (relevant for energy balance), boosts basal metabolic rate (thermogenesis), and promotes lipolysis (fat breakdown)

Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Serve over rice or preferred grain

GLP-1 medication may work faster or slower for each person, depending on their health and lifestyle, especially with weight loss